Raymond James Financial’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$126M Buy
493,287
+39
+0% +$9.6K 0.03% 454
2026
Q2
$92.3M Buy
493,248
+34,959
+8% +$6.43M 0.03% 609
2026
Q1
$86.4M Sell
458,289
-190,950
-29% -$40.2M 0.03% 567
2025
Q4
$129M Sell
649,239
-11,349
-2% -$2.29M 0.04% 406
2025
Q3
$134M Sell
660,588
-10,614
-2% -$1.88M 0.04% 391
2025
Q2
$118M Buy
671,202
+214,871
+47% +$32.3M 0.04% 418
2025
Q1
$61.4M Buy
456,331
+68,150
+18% +$8.97M 0.02% 622
2024
Q4
$49M Buy
+388,181
New +$57.7M 0.02% 733

Other funds holding THC

Raymond James Financial's THC Position: Q3 2026 in Review

Raymond James Financial increased its Tenet Healthcare (THC) stake by 0.01% in Q3 2026, buying an estimated $9.6K and bringing the position to 493,287 shares worth $126M. The position accounts for 0.03% of the portfolio, ranked #454.

Raymond James Financial first reported a position in THC in Q4 2024 and has held it in 8 quarters since. The position peaked at $134M in Q3 2025. 778 funds tracked by Wall St. Rank hold THC as of Q3 2026.

  • Raymond James Financial held 493,287 shares of Tenet Healthcare worth $126M as of Q3 2026.
  • Raymond James Financial bought 39 Tenet Healthcare shares in Q3 2026, an estimated $9.6K.
  • Tenet Healthcare made up 0.03% of Raymond James Financial's portfolio in Q3 2026, its #454 holding.
  • Raymond James Financial first reported a position in Tenet Healthcare in Q4 2024 and has held it in 8 quarters since.
  • Raymond James Financial's Tenet Healthcare position peaked at $134M in Q3 2025.
  • 778 funds tracked by Wall St. Rank held Tenet Healthcare as of Q3 2026.

Based on Raymond James Financial's 13F filing for Q3 2026, filed 12 Nov 2026.